An integrated network toxicology and multi-omics framework prioritizes BRCA1 as a testable candidate in

Weijia Ye1, Zhenyi Liu2, Peng He1

  • 1Department of Stomatology, Lishui Central Hospital, Lishui, Zhejiang, China.

Frontiers in Pharmacology
|September 30, 2026
PubMed